Cargando…

Upregulation of Oxytocin Receptor in the Hyperplastic Prostate

Background: The etiology of benign prostatic hyperplasia (BPH) is complex, both age and androgen are thought to be important. However, the failure of androgen blockade treatments suggests other paracrine/autocrine factors involved in BPH. Oxytocin was found to have a paracrine/autocrine role in pros...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhuo, Xiao, He, Wang, Kebing, Zheng, Yuelan, Chen, Ping, Wang, Xinghuan, DiSanto, Michael E., Zhang, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085439/
https://www.ncbi.nlm.nih.gov/pubmed/30123183
http://dx.doi.org/10.3389/fendo.2018.00403
_version_ 1783346326868590592
author Li, Zhuo
Xiao, He
Wang, Kebing
Zheng, Yuelan
Chen, Ping
Wang, Xinghuan
DiSanto, Michael E.
Zhang, Xinhua
author_facet Li, Zhuo
Xiao, He
Wang, Kebing
Zheng, Yuelan
Chen, Ping
Wang, Xinghuan
DiSanto, Michael E.
Zhang, Xinhua
author_sort Li, Zhuo
collection PubMed
description Background: The etiology of benign prostatic hyperplasia (BPH) is complex, both age and androgen are thought to be important. However, the failure of androgen blockade treatments suggests other paracrine/autocrine factors involved in BPH. Oxytocin was found to have a paracrine/autocrine role in prostate in recent years. The influence of BPH on prostatic oxytocin receptor (OTR) expression has never been studied. Material and methods: A testosterone-estradiol induced rat model of BPH was employed and human hyperplastic prostate specimens were harvested. Expressions of OTR, α(1)-adrenoreceptor subtypes and nitric oxide synthase isoforms were determined via real-time RT-PCR. OTR was further analyzed with Western-Blotting and histological examination. Subsequently, rat epithelial cells, human stromal cells and epithelial cells were cultured in vitro and treated with gradient concentrations of OT from 1 to 5 days. Cell proliferation was tested by Cell Counting Kit-8 and Flow Cytometry. Results: The rat BPH model was validated with significant increased prostate weight. H-E stain revealed a different histopathology between human and rat BPH. Masson's trichrome staining demonstrated that smooth muscle (SM) cells, epithelium cells and collagen fibers were simultaneously augmented in this rat BPH model and human BPH samples. OTR mainly localized in epithelium in rat prostate whereas it mainly localized in stroma in human prostate. OTR gene was upregulated 3.3-fold in rat BPH and 3.0-fold in human BPH, along with increased expression of 2.0-fold α(1a)ARs and 3.0-fold eNOS for rat BPH and 5.0-fold α(1a)ARs for human BPH. The expression of OTR protein was upregulated 1.4-fold in rat BPH and 3.9-fold in human BPH, respectively. Increased concentrations of exogenous OT can accelerate proliferation of rat epithelial cells and human stromal cells but has no impact on human epithelial cells in vitro. Flow Cytometry showed oxytocin could significantly increase G(2)/M period cell number. Conclusions: Our novel data demonstrates a significant and previously undocumented upregulation of OTR in both rat and human BPH. Moreover, exogenous OT accelerates proliferation of rat prostate epithelial cells and human prostate stromal cells. It is suggested OTR is involved in the development of BPH and OT regulatory system could be a potential new target for the BPH treatment.
format Online
Article
Text
id pubmed-6085439
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60854392018-08-17 Upregulation of Oxytocin Receptor in the Hyperplastic Prostate Li, Zhuo Xiao, He Wang, Kebing Zheng, Yuelan Chen, Ping Wang, Xinghuan DiSanto, Michael E. Zhang, Xinhua Front Endocrinol (Lausanne) Endocrinology Background: The etiology of benign prostatic hyperplasia (BPH) is complex, both age and androgen are thought to be important. However, the failure of androgen blockade treatments suggests other paracrine/autocrine factors involved in BPH. Oxytocin was found to have a paracrine/autocrine role in prostate in recent years. The influence of BPH on prostatic oxytocin receptor (OTR) expression has never been studied. Material and methods: A testosterone-estradiol induced rat model of BPH was employed and human hyperplastic prostate specimens were harvested. Expressions of OTR, α(1)-adrenoreceptor subtypes and nitric oxide synthase isoforms were determined via real-time RT-PCR. OTR was further analyzed with Western-Blotting and histological examination. Subsequently, rat epithelial cells, human stromal cells and epithelial cells were cultured in vitro and treated with gradient concentrations of OT from 1 to 5 days. Cell proliferation was tested by Cell Counting Kit-8 and Flow Cytometry. Results: The rat BPH model was validated with significant increased prostate weight. H-E stain revealed a different histopathology between human and rat BPH. Masson's trichrome staining demonstrated that smooth muscle (SM) cells, epithelium cells and collagen fibers were simultaneously augmented in this rat BPH model and human BPH samples. OTR mainly localized in epithelium in rat prostate whereas it mainly localized in stroma in human prostate. OTR gene was upregulated 3.3-fold in rat BPH and 3.0-fold in human BPH, along with increased expression of 2.0-fold α(1a)ARs and 3.0-fold eNOS for rat BPH and 5.0-fold α(1a)ARs for human BPH. The expression of OTR protein was upregulated 1.4-fold in rat BPH and 3.9-fold in human BPH, respectively. Increased concentrations of exogenous OT can accelerate proliferation of rat epithelial cells and human stromal cells but has no impact on human epithelial cells in vitro. Flow Cytometry showed oxytocin could significantly increase G(2)/M period cell number. Conclusions: Our novel data demonstrates a significant and previously undocumented upregulation of OTR in both rat and human BPH. Moreover, exogenous OT accelerates proliferation of rat prostate epithelial cells and human prostate stromal cells. It is suggested OTR is involved in the development of BPH and OT regulatory system could be a potential new target for the BPH treatment. Frontiers Media S.A. 2018-08-03 /pmc/articles/PMC6085439/ /pubmed/30123183 http://dx.doi.org/10.3389/fendo.2018.00403 Text en Copyright © 2018 Li, Xiao, Wang, Zheng, Chen, Wang, DiSanto and Zhang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Li, Zhuo
Xiao, He
Wang, Kebing
Zheng, Yuelan
Chen, Ping
Wang, Xinghuan
DiSanto, Michael E.
Zhang, Xinhua
Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
title Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
title_full Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
title_fullStr Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
title_full_unstemmed Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
title_short Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
title_sort upregulation of oxytocin receptor in the hyperplastic prostate
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085439/
https://www.ncbi.nlm.nih.gov/pubmed/30123183
http://dx.doi.org/10.3389/fendo.2018.00403
work_keys_str_mv AT lizhuo upregulationofoxytocinreceptorinthehyperplasticprostate
AT xiaohe upregulationofoxytocinreceptorinthehyperplasticprostate
AT wangkebing upregulationofoxytocinreceptorinthehyperplasticprostate
AT zhengyuelan upregulationofoxytocinreceptorinthehyperplasticprostate
AT chenping upregulationofoxytocinreceptorinthehyperplasticprostate
AT wangxinghuan upregulationofoxytocinreceptorinthehyperplasticprostate
AT disantomichaele upregulationofoxytocinreceptorinthehyperplasticprostate
AT zhangxinhua upregulationofoxytocinreceptorinthehyperplasticprostate